During an Afternoon trade, Shares of CBRE Clarion Global Real Estate Incm Fd (NYSE:IGR), climbed 0.27%, and is now trading at $7.43.
CBRE Clarion Global Real Estate Income Fund is a closed-end fund. The Fund’s primary objective is high current income and its secondary objective is capital appreciation. The Fund invests from 80% to 100% of its total assets in income-producing real estate securities (counting REITs) located mainly in the developed markets of North America, Europe, Australia and Asia.
CBRE Clarion Global Real Estate Income Fund declared a monthly distribution of $0.05 per share for the month of September 2015.
IGR’s current annualized distribution rate is 8.3% based on the closing market price of $7.22 on September 9, 2015, and 6.9% on a closing NAV of $8.74 as of the same date.
The Fund’s distribution policy is established by its Board of Trustees. The monthly distribution is set by the Board at regular intervals with consideration of investment income, realized gains, return of capital by portfolio companies, potential net appreciation of investments in “passive foreign investment companies” (“PFICs”), and other net unrealized appreciation and other income predictable for the year. Each distribution is predictable to be paid from some or all of the following sources: net investment income, realized capital gains and, in certain cases, return of capital. The Fund’s distribution rate should not be confused with pure income or yield. The Fund strives to establish a level monthly distribution that, over the course of the year, will serve to distribute an amount closely approximating the total taxable income of the Fund and all of the returns of capital by portfolio companies received by the Fund during the year.
Shares of C R Bard Inc (NYSE:BCR), climbed 1.21%, and is now trading at $197.21.
C R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias.
C R. Bard, declared that it will present at the Morgan Stanley Global Healthcare Conference in New York City on September 17, 2015. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation planned to start at 1:30 PM Eastern Daylight Time.
Notes to the Stakeholders:
This article is the intellectual property of www.jbhnews.com. The purpose of penning down this article has been just to share information. Moreover, it is firmly believed that all the information that are revealed in this article are from reliable sources, however, we do not make any representations or warranties whatsoever of any kind, express or implied, as far as the completeness, accurateness, or reliability with respect to this article is concerned.
All the respectable visitors to this website are kindly advised to conduct their own independent research into individual stocks prior to making a purchase decision.
This article contains an advanced information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as well as statements regarding the forseeable frequent growth of the market for the corporation’s products, the corporation’s capability to fund its capital requirement in the close-to term and in the long term; pricing pressures; etc.
Furthermore, any statement that expresses or involves discussions with respect to forecast, expectations, beliefs, strategy, projection, objectives, aims, assumption, or future events or performance may be forward looking statements. In addition, the forward-looking statements are wholly and solely based upon expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. An easy way to identify the forward looking statements is through the use of such words as be expecting, will, foresee, guess, considered, or by statements that indicates certain actions may, could, should/might occur.